Amazon.com, Inc. vs XPeng Inc. — Stock Comparison
Q·Score Breakdown
8.1
Bullish
Overall
7.3
Bullish
Quality
Health
Growth
Valuation
Sentiment
AMZN
Earnings growing 75% year-over-year on 17% revenue growth.
XPEV
Consistently beats earnings estimates (4/4 quarters).
⚠ currently unprofitable (-1% margin).
Analyst Consensus
BUY
Target $304.66 (+13.6%)
63 analysts
BUY
Target $24.67 (+55.9%)
26 analysts
Fundamentals
AMZN
XPEV
32.1×
Trailing P/E
—
27.2×
Forward P/E
23.0×
12.2%
Profit Margin
-1.5%
50.6%
Gross Margin
19.0%
24.3%
ROE
-3.7%
16.6%
Revenue Growth
38.2%
74.8%
Earnings Growth
—
1.38
Beta
1.18
—
Price / Book
—
$2.88T
Market Cap
$15.1B
$184 – $274
52-Week Range
$15 – $28
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →